Valeant Pharma (VRX) Improves Q2 Results

August 7, 2013 6:44 AM

Valeant Pharmaceuticals International, Inc. (NYSE: VRX) reported Q2 EPS of ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found